SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
5.02
-0.41 (-7.55%)
At close: May 13, 2026, 4:00 PM EDT
5.12
+0.10 (1.99%)
After-hours: May 13, 2026, 7:07 PM EDT
SciSparc Employees
SciSparc had 2 employees as of December 31, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
$428,000
Profits / Employee
-$6,089,500
Market Cap
2.84M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 0 | - |
| Dec 31, 2021 | 3 | 1 | 50.00% |
| Dec 31, 2020 | 2 | -6 | -75.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 19 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Galmed Pharmaceuticals | 6 |
| Alzamend Neuro | 6 |
SPRC News
- 13 days ago - Neurothera Labs Announces Continuance into Ontario - TheNewswire
- 20 days ago - Neurothera Labs Engages bullVestor for Investor Relations Activities - TheNewswire
- 2 months ago - SciSparc discloses patent application for depression yherapy - TheFly
- 2 months ago - SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy - GlobeNewsWire
- 2 months ago - SciSparc’s Neurothera Labs announces publication of international patent - TheFly
- 2 months ago - SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - GlobeNewsWire
- 2 months ago - SciSparc says Neurothera Labs agrees to acquire majority stake in CliniQuantum - TheFly
- 2 months ago - SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails - GlobeNewsWire